VSTM (Verastem, Inc.) Wutah bathi ing taun lumaku

Simbol resmi perusahaan verastem.com (VSTM)

The speculative potential of Verastem, Inc. (VSTM) relies on the patent protection of its ovarian cancer therapy, which is reflected in the GURU.Markets terminal via the current YoY EPS growth rate. The 34.40 metric confirms the current level of efficiency. Verastem, Inc. (VSTM) is mitigating risks by developing inhibitors for rare tumors, yet it remains vulnerable to geopolitical disruptions in raw material supplies and the complexities of international scientific partnerships.

VSTM (Verastem) riwayat Wutah bathi ing taun lumaku saka 04.07.2022 nganti 11.11.2026

Rincian metrik komprehensif lan analitis Verastem, Inc. (VSTM)

- rega saham lan prakiraan rega para ahli:
Rega Verastem Oncology|VSTM - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Verastem Corp|VSTM - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham Verastem|VSTM - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas verastem.com|VSTM - Total Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Verastem, Inc.|VSTM - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal verastem.com|VSTM - Gunggung utang perusahaan|Utang-utang marang nilai buku Verastem Corp|VSTM - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Verastem|Rasio jangkoan perantara verastem.com
- indikator pendapatan resik lan kelipatan nilai:
VSTM - Penghasilan resik|Bathi resik mangsa ngarep Verastem, Inc.|VSTM - Pangali P/E|Pangali mangsa ngarep rega marang bathi Verastem Corp|VSTM - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Verastem Corp|VSTM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Verastem|VSTM - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan verastem.com|VSTM - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Verastem, Inc.
Pambiji fundamental:VSTM Verastem Oncology
Produk mawa merek Verastem Corp

Investors use this metric to evaluate net earnings per share dynamics, which serves as an indicator of capital management efficiency and business scaling. The metric's calculation logic is based on a percentage comparison of the current EPS against the same value from the previous year, and tracking annual EPS growth at a value of 34.40 currently reflects the absence of commercial sales for Verastem, Inc. prior to the market launch of its premium oncology drugs.

Pesaing langsung

GMAB: Wutah bathi resik saben siji saham kanggo taun lumaku|EXEL (Exelixis Corp) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Nuvalent Therapeutics|Wutah bathi saben saham ing taun lumaku Kymera Therapeutics (KYMR)|IDYA (ideayabio.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ELVN (Enliven Therapeutics, Inc.)|Owah-owahan bathi resik saben saham ing taun lumaku ORIC Pharmaceuticals Inc|Relay Pharma - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Nurix Corp|TYRA (Tyra Biosciences, Inc.) - Wutah bathi resik saben saham ing taun iki|GLUE: Wutah bathi resik saben siji saham kanggo taun lumaku|CGEM (Cullinan Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Immuneering Corp IMRX|Wutah bathi ing taun lumaku CCCC|Black Diamond Therapeutics, Inc - Wutah bathi saben saham ing taun iki|Repare Therapeutics - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku PMVP|KPTI: Wutah bathi resik saben saham ing taun iki|Propanc Biopharma Inc - Wutah bathi resik saben siji saham kanggo taun lumaku|BGMS: Wutah bathi ing taun lumaku|Aadi Bioscience, Inc. - Tambahing bathi saben saham ing taun lumaku|ALRN (Aileron Therapeutics Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Blueprint Medicines Corp BPMC|Wutah bathi saben saham ing taun lumaku GlycoMimetics, Inc. (GLYC)|SWTX (SpringWorks Therapeutics Inc.) - Tambahing bathi saben saham ing taun lumaku